Literature DB >> 27908389

Hypertension, Obesity, Diabetes, and Heart Failure-Free Survival: The Cardiovascular Disease Lifetime Risk Pooling Project.

Faraz S Ahmad1, Hongyan Ning2, Jonathan D Rich3, Clyde W Yancy3, Donald M Lloyd-Jones1, John T Wilkins4.   

Abstract

OBJECTIVES: This study was designed to quantify the relationship between the absence of heart failure risk factors in middle age and incident heart failure, heart failure-free survival, and overall survival.
BACKGROUND: Quantification of years lived free from heart failure in the context of risk factor burden in mid-life may improve risk communication and prevention efforts.
METHODS: We conducted a pooled, individual-level analysis sampling from communities across the United States as part of 4 cohort studies: the Framingham Heart, Framingham Offspring, Chicago Heart Association Detection Project in Industry, and ARIC (Atherosclerosis Risk In Communities) studies. Participants with and without hypertension (blood pressure ≥140/90 mm Hg or treatment), obesity (body mass index ≥30 kg/m2), or diabetes (fasting glucose ≥126 mg/dl or treatment), and combinations of these factors, at index ages of 45 years and 55 years through 95 years. Competing risk-adjusted Cox models, a modified Kaplan-Meier estimator, and Irwin's restricted mean were used to estimate the association between the absence of risk factors at mid-life and incident heart failure, heart failure-free survival, and overall survival.
RESULTS: For participants at age 45 years, over 516,537 person-years of follow-up, 1,677 incident heart failure events occurred. Men and women with no risk factors, compared to those with all 3, had 73% to 85% lower risks of incident heart failure. Men and women without hypertension, obesity, or diabetes at age 45 years lived on average 34.7 years and 38.0 years without incident heart failure, and they lived on average an additional 3 years to 15 years longer free of heart failure than those with 1, 2, or 3 risk factors. Similar trends were seen when stratified by race and at index age 55 years.
CONCLUSIONS: Prevention of hypertension, obesity, and diabetes by ages 45 years and 55 years may substantially prolong heart failure-free survival, decrease heart failure-related morbidity, and reduce the public health impact of heart failure. Copyright Â
© 2016 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  epidemiology; heart failure; prevention; risk factors

Mesh:

Year:  2016        PMID: 27908389      PMCID: PMC5582802          DOI: 10.1016/j.jchf.2016.08.001

Source DB:  PubMed          Journal:  JACC Heart Fail        ISSN: 2213-1779            Impact factor:   12.035


  42 in total

1.  Data Resource Profile: The Cardiovascular Disease Lifetime Risk Pooling Project.

Authors:  John T Wilkins; Kunal N Karmali; Mark D Huffman; Norrina B Allen; Hongyan Ning; Jarett D Berry; Daniel B Garside; Alan Dyer; Donald M Lloyd-Jones
Journal:  Int J Epidemiol       Date:  2015-08-14       Impact factor: 7.196

Review 2.  The progression of hypertensive heart disease.

Authors:  Mark H Drazner
Journal:  Circulation       Date:  2011-01-25       Impact factor: 29.690

3.  The population burden of heart failure attributable to modifiable risk factors: the ARIC (Atherosclerosis Risk in Communities) study.

Authors:  Christy L Avery; Laura R Loehr; Christopher Baggett; Patricia P Chang; Anna M Kucharska-Newton; Kunihiro Matsushita; Wayne D Rosamond; Gerardo Heiss
Journal:  J Am Coll Cardiol       Date:  2012-09-26       Impact factor: 24.094

4.  Applying Cox regression to competing risks.

Authors:  M Lunn; D McNeil
Journal:  Biometrics       Date:  1995-06       Impact factor: 2.571

Review 5.  Heart failure in African Americans: disparities can be overcome.

Authors:  Alok Sharma; Monica Colvin-Adams; Clyde W Yancy
Journal:  Cleve Clin J Med       Date:  2014-05       Impact factor: 2.321

6.  Novel metabolic risk factors for incident heart failure and their relationship with obesity: the MESA (Multi-Ethnic Study of Atherosclerosis) study.

Authors:  Hossein Bahrami; David A Bluemke; Richard Kronmal; Alain G Bertoni; Donald M Lloyd-Jones; Eyal Shahar; Moyses Szklo; João A C Lima
Journal:  J Am Coll Cardiol       Date:  2008-05-06       Impact factor: 24.094

7.  Quality of life and depressive symptoms in the elderly: a comparison between patients with heart failure and age- and gender-matched community controls.

Authors:  Ivonne Lesman-Leegte; Tiny Jaarsma; James C Coyne; Hans L Hillege; Dirk J Van Veldhuisen; Robbert Sanderman
Journal:  J Card Fail       Date:  2008-11-28       Impact factor: 5.712

8.  Predictors of heart failure among women with coronary disease.

Authors:  Kirsten Bibbins-Domingo; Feng Lin; Eric Vittinghoff; Elizabeth Barrett-Connor; Stephen B Hulley; Deborah Grady; Michael G Shlipak
Journal:  Circulation       Date:  2004-09-07       Impact factor: 29.690

9.  Lifetime risk for heart failure among white and black Americans: cardiovascular lifetime risk pooling project.

Authors:  Mark D Huffman; Jarett D Berry; Hongyan Ning; Alan R Dyer; Daniel B Garside; Xuan Cai; Martha L Daviglus; Donald M Lloyd-Jones
Journal:  J Am Coll Cardiol       Date:  2013-04-09       Impact factor: 24.094

10.  The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators.

Authors: 
Journal:  Am J Epidemiol       Date:  1989-04       Impact factor: 4.897

View more
  39 in total

1.  Brown Adipocyte-Specific PPARγ (Peroxisome Proliferator-Activated Receptor γ) Deletion Impairs Perivascular Adipose Tissue Development and Enhances Atherosclerosis in Mice.

Authors:  Wenhao Xiong; Xiangjie Zhao; Luis Villacorta; Oren Rom; Minerva T Garcia-Barrio; Yanhong Guo; Yanbo Fan; Tianqing Zhu; Jifeng Zhang; Rong Zeng; Y Eugene Chen; Zhisheng Jiang; Lin Chang
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-08       Impact factor: 8.311

Review 2.  Obesity and Cardiometabolic Defects in Heart Failure Pathology.

Authors:  Ganesh V Halade; Vasundhara Kain
Journal:  Compr Physiol       Date:  2017-09-12       Impact factor: 9.090

Review 3.  Morbid Obesity as a Therapeutic Target for Heart Failure.

Authors:  Chonyang L Albert
Journal:  Curr Treat Options Cardiovasc Med       Date:  2019-09-05

Review 4.  Cardiovascular Risk in Patients with Prehypertension and the Metabolic Syndrome.

Authors:  Sergey Kachur; Rebecca Morera; Alban De Schutter; Carl J Lavie
Journal:  Curr Hypertens Rep       Date:  2018-03-06       Impact factor: 5.369

Review 5.  Clinical Outcomes, Trends in Weight, and Weight Loss Strategies in Patients With Obesity After Durable Ventricular Assist Device Implantation.

Authors:  Naga Vaishnavi Gadela; Devika Umashanker; Andrew Scatola; Abhishek Jaiswal
Journal:  Curr Heart Fail Rep       Date:  2021-01-09

6.  Epigenetic therapies in heart failure.

Authors:  Michael Alexanian; Arun Padmanabhan; Timothy A McKinsey; Saptarsi M Haldar
Journal:  J Mol Cell Cardiol       Date:  2019-04-13       Impact factor: 5.000

7.  Association of Midlife Cardiovascular Risk Factors With the Risk of Heart Failure Subtypes Later in Life.

Authors:  Laura P Cohen; Eric Vittinghoff; Mark J Pletcher; Norrina B Allen; Sanjiv J Shah; John T Wilkins; Patricia P Chang; Chiadi E Ndumele; Anne B Newman; Diane Ives; Mathew S Maurer; Elizabeth C Oelsner; Andrew E Moran; Yiyi Zhang
Journal:  J Card Fail       Date:  2020-11-22       Impact factor: 5.712

8.  Worsening Kidney Function Is the Major Mechanism of Heart Failure in Hypertension: The ALLHAT Study.

Authors:  Maedeh Khayyat-Kholghi; Suzanne Oparil; Barry R Davis; Larisa G Tereshchenko
Journal:  JACC Heart Fail       Date:  2020-11-11       Impact factor: 12.035

9.  Diabetes mellitus aggravates ranolazine-induced ECG changes in rats.

Authors:  Habibeh Mashayekhi-Sardoo; Amir Hooshang Mohammadpour; Soghra Mehri; Hossein Kamali; Amirhossein Sahebkar; Mohsen Imenshahidi
Journal:  J Interv Card Electrophysiol       Date:  2021-06-21       Impact factor: 1.900

10.  Bioelectrical impedance analysis versus quantitative computer tomography and anthropometry for the assessment of body composition parameters in China.

Authors:  Qian Qin; Yang Yang; Jingfeng Chen; Yaojun Jiang; Ang Li; Meng Huang; Yihan Dong; Shoujun Wang; Suying Ding
Journal:  Sci Rep       Date:  2021-05-26       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.